Ignite Creation Date:
2024-05-05 @ 5:34 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00484549
Status:
COMPLETED
Last Update Posted:
2009-12-21
First Post:
2007-06-08
Brief Title:
Fabry National Initiative of Screening
Sponsor:
University Hospital Clermont-Ferrand
Organization:
University Hospital Clermont-Ferrand
Study Overview
Official Title:
National Multicenter Prospective Study of Screening of Fabry Disease in a Population of Men Over 28 Days Old and Less Than 55 Years Hospitalized for an Ischemic Stroke
Status:
COMPLETED
Status Verified Date:
2009-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FIND
Brief Summary:
Fabry disease is a genetic disease due to an enzymatic deficit A screening of this disease allows patients to benefit from an enzyme replacement therapy and prevent the occurrence of life threatening manifestations such as an ischemic stroke
The purpose of the study is to determinate the prevalence of Fabry disease in a population of male patients hospitalized for an ischemic stroke
This study with a screening of Fabry disease allows the patients to make a precise diagnosis of their ischemic stroke and to facilitate the screening of the other members at the facility
The purpose of the study is to determinate the prevalence of Fabry disease in a population of male patients hospitalized for an ischemic stroke
This study with a screening of Fabry disease allows the patients to make a precise diagnosis of their ischemic stroke and to facilitate the screening of the other members at the facility
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None